Compounded Semaglutide Injectable Recalled Due to Sterility Failure
Payless Compounders is recalling a compounded semaglutide injectable due to lack of sterility assurance. The recall affects 91 vials distributed in Oregon.
- Product
- Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
- Category
- Drug
- Distribution
- 1 state